Table of Contents

1 Study Coverage

• 1.1 Allergic Rhinitis Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Allergic Rhinitis Market Size Growth Rate by Product
  • 1.4.2 Solid
  • 1.4.3 Liquid
• 1.5 Market by End User
  • 1.5.1 Global Allergic Rhinitis Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Research
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Allergic Rhinitis Market Size
  • 2.1.1 Global Allergic Rhinitis Revenue 2014-2025
  • 2.1.2 Global Allergic Rhinitis Sales 2014-2025
• 2.2 Allergic Rhinitis Growth Rate by Regions
  • 2.2.1 Global Allergic Rhinitis Sales by Regions
  • 2.2.2 Global Allergic Rhinitis Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Allergic Rhinitis Sales by Manufacturers
  • 3.1.1 Allergic Rhinitis Sales by Manufacturers
  • 3.1.2 Allergic Rhinitis Sales Market Share by Manufacturers
  • 3.1.3 Global Allergic Rhinitis Market Concentration Ratio (CR5 and HHI)
• 3.2 Allergic Rhinitis Revenue by Manufacturers
  • 3.2.1 Allergic Rhinitis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Allergic Rhinitis Revenue Share by Manufacturers (2014-2019)
• 3.3 Allergic Rhinitis Price by Manufacturers
• 3.4 Allergic Rhinitis Manufacturing Base Distribution, Product Types
  • 3.4.1 Allergic Rhinitis Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Allergic Rhinitis Product Type
  • 3.4.3 Date of International Manufacturers Enter into Allergic Rhinitis Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Allergic Rhinitis Sales by Product
• 4.2 Global Allergic Rhinitis Revenue by Product
• 4.3 Allergic Rhinitis Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Allergic Rhinitis Breakdown Data by End User

6 North America

• 6.1 North America Allergic Rhinitis by Countries
  • 6.1.1 North America Allergic Rhinitis Sales by Countries
  • 6.1.2 North America Allergic Rhinitis Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Allergic Rhinitis by Product
• 6.3 North America Allergic Rhinitis by End User

7 Europe

• 7.1 Europe Allergic Rhinitis by Countries
  • 7.1.1 Europe Allergic Rhinitis Sales by Countries
  • 7.1.2 Europe Allergic Rhinitis Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Allergic Rhinitis by Product
• 7.3 Europe Allergic Rhinitis by End User

8 Asia Pacific

• 8.1 Asia Pacific Allergic Rhinitis by Countries
  • 8.1.1 Asia Pacific Allergic Rhinitis Sales by Countries
  • 8.1.2 Asia Pacific Allergic Rhinitis Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Allergic Rhinitis by Product
• 8.3 Asia Pacific Allergic Rhinitis by End User

9 Central & South America

• 9.1 Central & South America Allergic Rhinitis by Countries
  • 9.1.1 Central & South America Allergic Rhinitis Sales by Countries
  • 9.1.2 Central & South America Allergic Rhinitis Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Allergic Rhinitis by Product
• 9.3 Central & South America Allergic Rhinitis by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Allergic Rhinitis by Countries
  • 10.1.1 Middle East and Africa Allergic Rhinitis Sales by Countries
  • 10.1.2 Middle East and Africa Allergic Rhinitis Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Allergic Rhinitis by Product
• 10.3 Middle East and Africa Allergic Rhinitis by End User

11 Company Profiles

• 11.1 GlaxoSmithKline
  • 11.1.1 GlaxoSmithKline Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 GlaxoSmithKline Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 GlaxoSmithKline Allergic Rhinitis Products Offered
  • 11.1.5 GlaxoSmithKline Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Allergic Rhinitis Products Offered
  • 11.2.5 Sanofi Recent Development
• 11.3 ALK-Abell
  • 11.3.1 ALK-Abell Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 ALK-Abell Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 ALK-Abell Allergic Rhinitis Products Offered
  • 11.3.5 ALK-Abell Recent Development
• 11.4 Meda Pharmaceuticals
  • 11.4.1 Meda Pharmaceuticals Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Meda Pharmaceuticals Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Meda Pharmaceuticals Allergic Rhinitis Products Offered
  • 11.4.5 Meda Pharmaceuticals Recent Development
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Merck Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Merck Allergic Rhinitis Products Offered
  • 11.5.5 Merck Recent Development
• 11.6 Boehringer Ingelheim
  • 11.6.1 Boehringer Ingelheim Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Boehringer Ingelheim Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Boehringer Ingelheim Allergic Rhinitis Products Offered
  • 11.6.5 Boehringer Ingelheim Recent Development
• 11.7 AstraZeneca
  • 11.7.1 AstraZeneca Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 AstraZeneca Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 AstraZeneca Allergic Rhinitis Products Offered
  • 11.7.5 AstraZeneca Recent Development
• 11.8 Johnson & Johnson
  • 11.8.1 Johnson & Johnson Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Johnson & Johnson Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Johnson & Johnson Allergic Rhinitis Products Offered
  • 11.8.5 Johnson & Johnson Recent Development
• 11.9 Teva
  • 11.9.1 Teva Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Teva Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Teva Allergic Rhinitis Products Offered
  • 11.9.5 Teva Recent Development
• 11.10 Alcon (Novartis)
  • 11.10.1 Alcon (Novartis) Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Alcon (Novartis) Allergic Rhinitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Alcon (Novartis) Allergic Rhinitis Products Offered
  • 11.10.5 Alcon (Novartis) Recent Development

12 Future Forecast

• 12.1 Allergic Rhinitis Market Forecast by Regions
  • 12.1.1 Global Allergic Rhinitis Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Allergic Rhinitis Revenue Forecast by Regions 2019-2025
• 12.2 Allergic Rhinitis Market Forecast by Product
  • 12.2.1 Global Allergic Rhinitis Sales Forecast by Product 2019-2025
  • 12.2.2 Global Allergic Rhinitis Revenue Forecast by Product 2019-2025
• 12.3 Allergic Rhinitis Market Forecast by End User
• 12.4 North America Allergic Rhinitis Forecast
• 12.5 Europe Allergic Rhinitis Forecast
• 12.6 Asia Pacific Allergic Rhinitis Forecast
• 12.7 Central & South America Allergic Rhinitis Forecast
• 12.8 Middle East and Africa Allergic Rhinitis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Allergic Rhinitis Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

An allergen is an otherwise harmless substance that has the ability to cause an allergic reaction in conducive conditions. Allergic rhinitis is an allergic response to specific allergens. Pollen is the most common allergen in seasonal allergic rhinitis.
The global Allergic Rhinitis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Allergic Rhinitis market based on company, product type, end user and key regions.

This report studies the global market size of Allergic Rhinitis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Allergic Rhinitis in these regions.
This research report categorizes the global Allergic Rhinitis market by top players/brands, region, type and end user. This report also studies the global Allergic Rhinitis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Sanofi
ALK-Abell
Meda Pharmaceuticals
Merck
Boehringer Ingelheim
AstraZeneca
Johnson & Johnson
Teva
Alcon (Novartis)

Market size by Product
By form
Solid
Liquid
By drug class
Antihistamines
Intranasal corticosteroids
Immunotherapies
By route of administration
Oral
Parenteral
Intranasal
Market size by End User
Hospital
Clinic
Research

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Allergic Rhinitis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Allergic Rhinitis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Allergic Rhinitis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Allergic Rhinitis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Allergic Rhinitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Allergic Rhinitis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.